LONDON, January 30, 2018 /PRNewswire/ —
REX-001 is a novel cell therapy for the treatment of Critical Limb Ischemia (CLI), a disease which affects an estimated one million people in Europe
Rexgenero Ltd, a clinical-stage regenerative medicine company developing advanced…